News UK court overturns AbbVie Humira patents Decision paves way for cheaper competitor in autumn 2018.
News Amgen's Humira biosimilar first to gain EU nod But patents could delay launch for more than a year.
News New Gilead and AbbVie hepatitis C combos filed in EU Companies aim to cut treatment time and side effects.
News J&J/AbbVie blood cancer drug gets fifth US indication Imbruvica approved in marginal zone lymphoma.
News Pharma criticises 'heavy handed' NICE affordability test NHS England and NICE are attempting to reduce budget impact of drugs.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
